contact us Contact Us Or call +44 (0)118 979 1169
  • About
    • Who are GRA?
    • Meet Lee
    • Associates
    • Testimonials
    • FAQs
  • Services
    • Biotech Consulting
    • Biotech Speaker
    • Training
  • Blog
  • Contact Us
  • Case Studies
  • Resources
    • Articles
    • Videos
    • Presentations
    • Free Templates
    • Newsletters
  • Search
  • Client Login
    • Trello
    • GoToMeeting
    • join me
  • Services
  • Biotech Consulting
    • Regulatory Affairs (RA)
    • Quality by Design (QbD)
    • Formulation Development
    • Vaccine Development
    • Process Characterization
    • Cell & Seed Bank Characterization
    • CMC
    • Commercial Support
    • Biotech Due Diligence
    • Product Characterisation
    • CMO Management
    • Licencing
    • Design of Experiments (DoE)
    • Process Validation
    • Analytical Development
  • Biotech Speaker
  • Training

Process Characterization

Process Characterization consultingWhilst developing a new biopharmaceutical product a manufacturing process will need to be developed that can be run to cGMP.  The critical quality attributes (CQAs) of the product will be decided and a process developed that can deliver on these attributes.  The process will be described and documented in detail to ensure that the CQAs can be met consistently to give a safe and efficacious product after every manufacturing run.

When developing a manufacturing process, intermediate products in the process will be tested at pre-determined points.  This to ensure that each step of the process is working as expected and that the process is operating within pre-defined operating parameters. At the end of the manufacturing run the final product will also be tested as part of its release.  As the manufacturing process is further refined and optimised as the product passes through the various phases of clinical trials, the process will be characterized using a battery of methods some of which are not performed during routine manufacturing as well as QC methods.  These characterization data can be used to understand the impact of process parameters and any changes to them upon the final product’s Critical Quality Attributes.  This allows a process control strategy to be defined that will be able to maintain consistent process performance.  This process understanding should also be linked to understanding how raw materials and reagents used in the process affect the final product.

GRA is experienced in helping clients characterize their processes in preparation for process validation exercises.  For biologics, it is becoming increasing common for processes to be validated prior to initiation of phase III clinical studies.  Therefore many organisations a performing process characterization during early development once the process is clearly defined.

  • Stay up
    to date

    Complete your details and we’ll send you regular updates via our newsletter.

  • Our newsletter



    • Resources

      Need to understand some element of the biopharma industry or looking for a particular template?

      Click here to see our free resources

    • About
      • Who are GRA?
      • Meet Lee
      • Associates
      • Testimonials
      • FAQs
    • Services
      • Biotech Consulting
      • Biotech Speaker
      • Training
    • Blog
    • Contact Us
    • Case Studies
    • Resources
      • Articles
      • Videos
      • Presentations
      • Free Templates
      • Newsletters
    Terms & Conditions Privacy Policy Cookies FAQs

    © 2023 GreyRigge Associates Limited. All rights reserved.

    Site design & build by Hinge Ltd.